European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations
-
- Stephan Miehlke
- Center for Digestive Diseases Internal Medicine Center Eppendorf Hamburg Germany
-
- Danila Guagnozzi
- Neuro‐Immuno‐Gastroenterology Group Digestive Physiology and Pathophysiology Unit Vall d'Hebron Research Institute (VHIR) Barcelona Spain
-
- Yamile Zabana
- Centro de Investigación Biomedica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Barcelona Spain
-
- Gian E. Tontini
- Department of Pathophysiology and Organ Transplantation University of Milan and Gastroenterology and Endoscopy Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
-
- Anne‐Marie Kanstrup Fiehn
- Department of Pathology Copenhagen University Hospital Rigshospitalet Denmark
-
- Signe Wildt
- Department of Gastroenterology Zealand University Hospital Koege Denmark
-
- Johan Bohr
- Department of Medicine Örebro University Hospital Örebro University Örebro Sweden
-
- Ole Bonderup
- Diagnostik Center Hospitalenhed Midt Regionshospitalet Silkeborg Silkeborg Denmark
-
- Gerd Bouma
- Department of Gastroenterology and Hepatology Vrije Universiteit Amsterdam Amsterdam the Netherlands
-
- Mauro D'Amato
- School of Biological Sciences Monash University Clayton Australia
-
- Peter J. Heiberg Engel
- Department of Pathology Zealand University Hospital Roskilde Denmark
-
- Fernando Fernandez‐Banares
- Centro de Investigación Biomedica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Barcelona Spain
-
- Gilles Macaigne
- Hepatogastroenterology Unit Centre Hospitalier de Marne‐la‐Vallee Jossigny France
-
- Henrik Hjortswang
- Department of Gastroenterology and Hepatology in Linköping Linköping University Linköping Sweden
-
- Elisabeth Hultgren‐Hörnquist
- School of Medical Sciences Örebro University Örebro Sweden
-
- Anastasios Koulaouzidis
- The Royal Infirmary of Edinburgh Endoscopy Unit Edinburgh UK
-
- Jouzas Kupcinskas
- Department of Gastroenterology and Institute for Digestive Research Lithuanian University of Health Sciences Kaunas Lithuania
-
- Stefania Landolfi
- Department of Pathology Hospital Universitari Vall d'Hebron CIBERONC Barcelona Spain
-
- Giovanni Latella
- Department of Life, Health and Environmental Sciences University of L'Aquila L'Aquila Italy
-
- Alfredo Lucendo
- Department of Gastroenterology Hospital General de Tomelloso Tomelloso Spain
-
- Ivan Lyutakov
- Department of Gastroenterology Medical University of Sofia University Hospital Tsaritsa Yoanna—ISUL Sofia Bulgaria
-
- Ahmed Madisch
- Department of Gastroenterology CRH Clinic Siloah Hannover Germany
-
- Fernando Magro
- Department of Pharmacology Hospital de Sao Joao Porto Portugal
-
- Wojciech Marlicz
- Department of Gastroenterology Pomeranian Medical University Szczecin Poland
-
- Emese Mihaly
- Department of Internal Medicine Semmelweis University Budapest Hungary
-
- Lars K. Munck
- Department of Gastroenterology Zealand University Hospital Koege Denmark
-
- Ann‐Elisabeth Ostvik
- Department of Clinical and Molecular Medicine NTNU: Norwegian University of Science and Technology Trondheim Norway
-
- Árpád V. Patai
- 2nd Department of Medicine Semmelweis University Budapest Hungary
-
- Plamen Penchev
- Department of Gastroenterology Medical University of Sofia University Hospital Tsaritsa Yoanna—ISUL Sofia Bulgaria
-
- Karolina Skonieczna‐Żydecka
- Department of Human Nutrition and Metabolomics Pomeranian Medical University Szczecin Poland
-
- Bas Verhaegh
- Department of Internal Medicine Maastricht University Medical Center Maastricht The Netherlands
-
- Andreas Münch
- Department of Gastroenterology and Hepatology in Linköping Linköping University Linköping Sweden
説明
<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Microscopic colitis is a chronic inflammatory bowel disease characterised by normal or almost normal endoscopic appearance of the colon, chronic watery, nonbloody diarrhoea and distinct histological abnormalities, which identify three histological subtypes, the collagenous colitis, the lymphocytic colitis and the incomplete microscopic colitis. With ongoing uncertainties and new developments in the clinical management of microscopic colitis, there is a need for evidence‐based guidelines to improve the medical care of patients suffering from this disorder.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Guidelines were developed by members from the European Microscopic Colitis Group and United European Gastroenterology in accordance with the Appraisal of Guidelines for Research and Evaluation II instrument. Following a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the certainty of the evidence. Statements and recommendations were developed by working groups consisting of gastroenterologists, pathologists and basic scientists, and voted upon using the Delphi method.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>These guidelines provide information on epidemiology and risk factors of microscopic colitis, as well as evidence‐based statements and recommendations on diagnostic criteria and treatment options, including oral budesonide, bile acid binders, immunomodulators and biologics. Recommendations on the clinical management of microscopic colitis are provided based on evidence, expert opinion and best clinical practice.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>These guidelines may support clinicians worldwide to improve the clinical management of patients with microscopic colitis.</jats:p></jats:sec>
収録刊行物
-
- United European Gastroenterology Journal
-
United European Gastroenterology Journal 9 (1), 13-37, 2021-02
Wiley